Both in Pharmaceuticals
Mineralys Therapeutics vs AnaptysBio
Over the past year MLYS returned −60.3% and ANAB returned +30.2%; their daily moves had a correlation of 0.09.
MLYS −60.3% ANAB +30.2%Growth of $1, one year, split-adjusted
| Metric | MLYS | ANAB |
|---|---|---|
| Price | $15.55 | $46.91 |
| Market cap | $1.37B | $1.40B |
| Today | −14.47% | −2.84% |
| 1 month | −34.2% | −3.3% |
| 6 months | −47.6% | −32.8% |
| Year to date | −57.2% | −3.2% |
| 1 year | −62.2% | +28.6% |
| Revenue growth (YoY) | — | −8.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −206.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.0× |
| Net cash | $563.8M | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 41.0% |
| Short % of float | 11.6% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).